Do you want to read an article? Please log in or register.
Genetic testing is essential for initiating statin therapy in children with familial hypercholesterolemia: Examples from Scandinavia
Further Publications
Related content
Cardiovascular Risk and DiseasesHeart, Artery and Coronary DiseasesLipid-Lowering Drugs
Statins for children with familial hypercholesterolemia
Cochrane Database Syst Rev.
Vuorio A, Kuoppala J, Kovanen PT, Humphries SE, Tonstad S, Wiegman A, Drogari E, Ramaswami U
doi: 10.1002/14651858.
Cardiovascular Risk and DiseasesHeart, Artery and Coronary DiseasesLipid-Lowering Drugs
Efficacy of Rosuvastatin in Children With Homozygous Familial Hypercholesterolemia and Association With Underlying Genetic Mutations
J Am Coll Cardiol.
Stein EA, Dann EJ, Wiegman A, Skovby F, Gaudet D, Sokal E, Charng MJ, Mohamed M, Luirink I, Raichlen JS, Sundén M, Carlsson SC, Raal FJ, Kastelein JJP
doi: 10.1016/j.jacc.2017.06.058.
Heart, Artery and Coronary DiseasesLipid-Lowering Drugs
Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children with Heterozygous Familial Hypercholesterolemia: The CHARON Study
Circulation.
Braamskamp MJAM, Langslet G, McCrindle BW, Cassiman DM, Francis GA, Gagne C, Gaudet D, Morrison KM, Wiegman A, Turner T, Miller E, Kusters DM, Raichlen JS, Martin PD, Stein EA, Kastelein JJP, Hutten BA
doi: 10.1161/CIRCULATIONAHA.
RECOMMENDED
Heart, Artery and Coronary DiseasesLipid-Lowering Drugs
Long term follow-up of genetically confirmed patients with familial hypercholesterolemia treated with first and second-generation statins and then with PCSK9 monoclonal antibodies
★ 2
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Atherosclerosis.
Pasta A, Cremonini AL, Formisano E, Fresa R, Bertolini S, Pisciotta L
doi: 10.1016/j.atherosclerosis.2020.07.006.
Cardiovascular Risk and DiseasesHeart, Artery and Coronary Diseases
Role of Genetic Testing in Inherited Cardiovascular Disease: A Review
JAMA Cardiol.
Cirino AL, Harris S, Lakdawala NK, Michels M, Olivotto I, Day SM, Abrams DJ, Charron P, Caleshu C, Semsarian C, Ingles J, Rakowski H, Judge DP, Ho CY
doi: 10.1001/jamacardio.
Cardiovascular Risk and DiseasesHeart, Artery and Coronary DiseasesLipid-Lowering Drugs
Incorporating Genetic Testing Into Cardiovascular Practice
JAMA Cardiol.
McNally EM
doi: 10.1001/jamacardio.
RECOMMENDED
Heart, Artery and Coronary DiseasesLipid-Lowering Drugs
Evinacumab for Homozygous Familial Hypercholesterolemia
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
N Engl J Med.
Raal FJ, Rosenson RS, Reeskamp LF, Hovingh GK, Kastelein JJP, Rubba P, Ali S, Banerjee P, Chan KC, Gipe DA, Khilla N, Pordy R, Weinreich DM, Yancopoulos GD, Zhang Y, Gaudet D, ELIPSE HoFH Investigators
doi: 10.1056/NEJMoa2004215.
Cardiovascular Risk and DiseasesHeart, Artery and Coronary DiseasesLipid-Lowering DrugsMyocardial InfarctionThrombosis and Stroke
Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease
JAMA.
Kazi DS, Moran AE, Coxson PG, Penko J, Ollendorf DA, Pearson SD, Tice JA, Guzman D, Bibbins-Domingo K.
doi: 10.1001/jama.2016.11004.
COMMENTED
Heart, Artery and Coronary Diseases
Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action
★ 3
Recommended and commented by
Prof. Dr Isabella Sudano, Faculty Member
doi: 10.1001/jamacardio.2019.5173.